Search Results

There are 16574 results for: content related to: Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases §

  1. You have free access to this content
    Rituximab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Maria Angeles Lopez-Olivo, Matxalen Amezaga Urruela, Lynda McGahan, Eduardo N Pollono and Maria E Suarez-Almazor

    Published Online : 20 JAN 2015, DOI: 10.1002/14651858.CD007356.pub2

  2. Rituximab in Severe Pemphigus

    Annals of the New York Academy of Sciences

    Volume 1173, Issue 1, September 2009, Pages: 683–691, Enno Schmidt, Matthias Goebeler and Detlef Zillikens

    Version of Record online : 1 SEP 2009, DOI: 10.1111/j.1749-6632.2009.04744.x

  3. You have full text access to this OnlineOpen article
    Rituximab in the treatment of autoimmune haematological disorders

    British Journal of Haematology

    Volume 141, Issue 2, April 2008, Pages: 149–169, Bernadette Garvey

    Version of Record online : 3 MAR 2008, DOI: 10.1111/j.1365-2141.2008.07054.x

  4. You have free access to this content
    Publications

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 244–321,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2229

  5. Rituximab as maintenance therapy for patients with follicular lymphoma

    Intervention Review

    The Cochrane Library

    Liat Vidal, Anat Gafter-Gvili, Leonard Leibovici and Ofer Shpilberg

    Published Online : 15 APR 2009, DOI: 10.1002/14651858.CD006552.pub2

  6. You have free access to this content
    Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients

    American Journal of Transplantation

    Volume 10, Issue 1, January 2010, Pages: 89–98, N. Kamar, O. Milioto, B. Puissant-Lubrano, L. Esposito, M. C. Pierre, A. Ould Mohamed, L. Lavayssière, O. Cointault, D. Ribes, I. Cardeau, M. B. Nogier, D. Durand, M. Abbal, A. Blancher and L. Rostaing

    Version of Record online : 28 JUL 2009, DOI: 10.1111/j.1600-6143.2009.02785.x

  7. You have free access to this content
    Poster Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 181–243,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2228

  8. You have free access to this content
    Rituximab in the treatment of autoimmune haemolytic anaemia

    British Journal of Clinical Pharmacology

    Volume 79, Issue 5, May 2015, Pages: 709–719, Chaturaka Rodrigo, Senaka Rajapakse and Lallindra Gooneratne

    Version of Record online : 22 APR 2015, DOI: 10.1111/bcp.12498

  9. You have free access to this content
    PUBLICATION

    Hematological Oncology

    Volume 31, Issue S1, June 2013, Pages: 201–270,

    Version of Record online : 17 JUN 2013, DOI: 10.1002/hon.2059

  10. Experience with low-dose rituximab in off-label indications at two tertiary hospitals

    Internal Medicine Journal

    Volume 43, Issue 8, August 2013, Pages: 871–882, J. Chay, P. Donovan, L. Cummins, P. Kubler and P. Pillans

    Version of Record online : 6 AUG 2013, DOI: 10.1111/imj.12207

  11. Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia

    Intervention Review

    The Cochrane Library

    Kathrin Bauer, Michaela Rancea, Verena Roloff, Thomas Elter, Michael Hallek, Andreas Engert and Nicole Skoetz

    Published Online : 14 NOV 2012, DOI: 10.1002/14651858.CD008079.pub2

  12. You have free access to this content
    Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders

    American Journal of Hematology

    Volume 86, Issue 3, March 2011, Pages: 278–291, Daan Dierickx, André Delannoy, Khalid Saja, Gregor Verhoef and Drew Provan

    Version of Record online : 15 FEB 2011, DOI: 10.1002/ajh.21939

  13. You have free access to this content
    Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab

    Transplant International

    Volume 19, Issue 4, April 2006, Pages: 259–269, Jakub Svoboda, Robert Kotloff and Donald E. Tsai

    Version of Record online : 27 MAR 2006, DOI: 10.1111/j.1432-2277.2006.00284.x

  14. Rituximab: Applications in dermatology

    International Journal of Dermatology

    Volume 45, Issue 10, October 2006, Pages: 1143–1155, Mitra M. Fatourechi, Rokea A. El-Azhary and Lawrence E. Gibson

    Version of Record online : 11 OCT 2006, DOI: 10.1111/j.1365-4632.2006.03007.x

  15. You have free access to this content
    CD20-depleting therapy in autoimmune diseases: from basic research to the clinic

    Journal of Internal Medicine

    Volume 267, Issue 3, March 2010, Pages: 260–277, F. Perosa, M. Prete, V. Racanelli and F. Dammacco

    Version of Record online : 15 DEC 2009, DOI: 10.1111/j.1365-2796.2009.02207.x

  16. You have free access to this content
    Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16

    British Journal of Haematology

    Volume 140, Issue 6, March 2008, Pages: 635–643, Christophe De Romeuf, Charles-Antoine Dutertre, Magali Le Garff-Tavernier, Nathalie Fournier, Christine Gaucher, Arnaud Glacet, Sylvie Jorieux, Nicolas Bihoreau, Christian K. Behrens, Roland Béliard, Vincent Vieillard, Bruno Cazin, Dominique Bourel, Jean-François Prost, Jean-Luc Teillaud and Hélène Merle-Béral

    Version of Record online : 21 FEB 2008, DOI: 10.1111/j.1365-2141.2007.06974.x

  17. You have free access to this content
    A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus–associated cryoglobulinemic vasculitis

    Arthritis & Rheumatism

    Volume 64, Issue 3, March 2012, Pages: 835–842, Michael C. Sneller, Zonghui Hu and Carol A. Langford

    Version of Record online : 28 FEB 2012, DOI: 10.1002/art.34322

  18. You have free access to this content
    British HIV Association guidelines for HIV-associated malignancies 2014

    HIV Medicine

    Volume 15, Issue S2, March 2014, Pages: 1–92, Writing Group, Prof Mark Bower, Dr A Palfreeman, Dr Maryam Alfa-Wali, Prof Chris Bunker, Dr Fiona Burns, Dr Duncan Churchill, Mr Simon Collins, Dr Kate Cwynarski, Dr Simon Edwards, Dr Paul Fields, Dr Kate Fife, Dr Eve Gallop-Evans, Dr Shireen Kassam, Dr Ranjababu Kulasegaram, Prof Charles Lacey, Dr Robert Marcus, Dr Sylvia Montoto, Dr Mark Nelson, Dr Tom Newsom-Davis, Dr Chloe Orkin, Ms Kate Shaw, Dr Melinda Tenant-Flowers, Dr Andrew Webb, Dr Sarah Westwell and Mr Matt Williams

    Version of Record online : 14 FEB 2014, DOI: 10.1111/hiv.12136

  19. You have free access to this content
    ORAL PRESENTATIONS

    Hematological Oncology

    Volume 31, Issue S1, June 2013, Pages: 96–150,

    Version of Record online : 17 JUN 2013, DOI: 10.1002/hon.2057

  20. You have free access to this content
    Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen

    British Journal of Haematology

    Volume 154, Issue 3, August 2011, Pages: 357–362, Steven P. Treon, Christina Hanzis, Robert J. Manning, Leukothea Ioakimidis, Christopher J. Patterson, Zachary R. Hunter, Patricia Sheehy and Barry Turnbull

    Version of Record online : 25 MAY 2011, DOI: 10.1111/j.1365-2141.2011.08750.x